Amphotericin-B is started empirically in a suspected case of CAM as a life-saving measure, but the stopping of its administration can be decided once the CRP levels show a decreasing trend or become normal.
← all excerpts
C-reactive Protein Kinetics During In-Patient Treatment of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
1
—
—